Skip to main content

Conversation with David Sym-Smith


David Sym-Smith, Partner at Addison, TX-based venture capital firm Mobility Ventures, is a 20+ veteran of the mobile industry. I met David about two months ago at the kick-off event for Health Wildcatters, a Dallas-based healthcare-oriented seed accelerator where David serves as a startup mentor (see my previous post about the kick-off event here). At the event we had a brief but fascinating conversation on mobile technologies and their impact on healthcare. We got together a few weeks later at a local Starbucks for a follow-up chat. I found the ensuing conversation so interesting that I asked David whether I could post a synopsis of our conversation on my blog; David kindly acquiesced. Below are some highlights from what David had to say: 

Indoor mapping is the next frontier in mapping. Companies involved in online maps and mobile navigation (e.g., Google, Apple, etc.) are all actively working on providing maps and navigation capabilities for indoor spaces (malls, stadiums, etc.) and tracking the locations of individuals within them. Unlike GPS, there is no standard method for building an indoor positioning system; as such, there are a variety of solutions currently out there. Most use some combination of information garnered from sensors built into mobile phones and from existing WiFi networks. There is one method that utilizes the Earth’s geomagnetic field (Indoor Atlas). The coming widespread availability of precise indoor spatial tracking will greatly enhance the power of existing “self-quantifying” tools that track one’s physical activity and status in real time (e.g., Nike+). This technology can be applied to a variety of medical uses. One example:  real-time tracking of, say, one's elderly mother within her own house. The data would be mined for changes in patterns of activity that might signal trouble, (e.g., did she get out of bed, etc.) and this information can be streamed to her healthcare provider(s) as well as to her adult children who may be worried about her health status. David says he would pay good money for such a service, and he is confident many other people would as well. 

Expect to see a trend of non-healthcare companies taking their existing technologies and applying them to healthcare. The reason – healthcare is where the big money is. Consider a company like [mapping and navigation company] Garmin, which is already active in sports and athletics. The technologies Garmin has already developed and deployed for athletics are very applicable to medicine (e.g., remote-monitoring). Because the healthcare market is potentially more lucrative, it would make a lot of sense for a company like Garmin to repackage their existing technologies for medical applications. 

Academic technology transfer. David pointed to Stanford as a model for academic technology transfer done right:  stick to licensing fees only – at a low percentage – to make it easy for businesses to bear the cost of paying for IP. This approach has paid off handsomely for Stanford. [Note: after my conversation with David I came across a great writeup on the success of Stanford's technology licensing efforts here -IH]

Startups and seed accelerators. David has been involved with screening applicants for the inaugural class of Health Wildcatters, the new Dallas-based healthcare-oriented seed accelerator. He feels the most important resource organizations like Health Wildcatters can provide to startup companies is access to mentors with deep connections in the industries they are attempting to enter. In addition to providing expertise, advice, and guidance, mentors often provide startups with introductions to potential investors and in some cases their first paying customers (particularly within a B2B setting). The actual funding that startup companies will receive from Health Wildcatters is, he feels, of secondary importance. 

– Isamu Hartman, PhD

Comments

Popular posts from this blog

Comics About Patents (A Work In Progress)

Back in January and February of 2018, I spent some time creating two four-panel comics about the process of 1) obtaining patent protection, and 2) monetizing those patent rights by licensing them. I drew the comics to serve as an illustration of concepts that I often find myself explaining to others in the course of my work. I've already shared these comics through  Twitter  and  Facebook  (click on either of link to see more of the creative process!). However, I thought I'd share them with my blog's readership as well. Please enjoy! I'm really hoping to reignite this project at some point in the future and create more episodes. (Click on the images below to enlarge) Episode 1: Episode 2: - Isamu Hartman

The Big Fish: Texas-Based Biomedical Companies listed on NYSE and NASDAQ

[Monday, 22 April 2013:  I added Hanger Inc. (HGR, NYSE), an Austin-based prosthetics and orthotics company I had originally missed, to the list] [Thursday, 02 May 2013:  fixed the location of Hanger Inc. (HGR, NYSE) - changed from Dallas to Austin] I have another few posts coming up on Texas-based awardees of the SBIR program. But first, a quick digression. +Levi Shapiro  asked me the following question during a phone conversation we had earlier today:  who are the "Big Players" in the Texas biomedical industry that are listed in the major stock exchanges? I knew about Luminex (LMNX, NASDAQ) off the top of my head. Other than that, though, I really had no idea. Following the advice of +Lauren Nise  , I used LexisNexis (courtesy of the UT Dallas Eugene McDermott Library ) to generate a list of publicly traded biomedical companies headquartered in Texas that are listed in either NYSE or NASDAQ. Here are the companies I found: (Open spreadsheet as a se...

Corporate Venture Capital at the Top 10 Pharma/Biotech Companies

Today I'm taking a step outside of Texas and looking at the world. Many large pharmaceutical and biotech firms maintain venture capital operations through which they invest in early-stage biomedical companies. I wanted to get a sense of what these biopharma corporate venture capital (CVC) funds are up to. Which companies have CVC funds? How active are they? What are their goals? What are they investing in? Background: general and sector-specific trends in venture capital In 2014 venture capital funding in the U.S. hit its highest annual mark since 2001, as investors participated in $47.3 billion across 3,617 deals . Within this trend Life Sciences was the second largest sector (behind only the Media and Entertainment sector) for 2014 in dollar terms with $8.6 billion invested in 789 deals, the highest level since 2007 . Corporate venture funding has followed similar trends:  2014 marked the strongest year for CVC activity since 2000 with $5.4 billion invested in U.S.-based co...